• 470 Citations
  • 8 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Isabella Capodanno is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Leukemia, Myeloid, Chronic Phase Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Quality of Life Medicine & Life Sciences
Observational Studies Medicine & Life Sciences
Pleural Effusion Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 470 Citations
  • 8 h-Index
  • 30 Article
  • 1 Letter

Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

Tiribelli, M., Abruzzese, E., Capodanno, I., Sorà, F., Trabacchi, E., Iurlo, A., Luciano, L., Binotto, G., Bonifacio, M., Annunziata, M., Crugnola, M. & Fanin, R., 2019, In : Annals of Hematology. 98, 11, p. 2609-2611

Research output: Contribution to journalLetter

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., 2019, In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre

Capodanno, I., Tamagnini, E., Alfieri, P., Codeluppi, K., Luminari, S. & Merli, F., Jan 1 2019, In : European Journal of Haematology.

Research output: Contribution to journalArticle

Terminal Care
Home Care Services
Palliative Care
Leukemia
Hospitalization

Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle